From: Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
Gene | Phase1 | ||||
---|---|---|---|---|---|
 |  |  |  | p-value3 | |
 | P/M1 (N = 22) | C1 (N = 32) | C2/C3 (N = 16) | P/M1 vs C1 | P/M1 vs C2/C3 |
APC | 2 (9.1) | 8 (25) | 7 (43.8) | 0.25 | 0.03 |
BRCA12 | 4 (18.2) | 12 (37.5) | 2 (13.3) | 0.22 | 1.0 |
HIC12 | 3 (13.6) | 11 (34.4) | 8 (53.5) | 0.17 | 0.09 |
MGMT | 0 | 11 (34.4) | 3 (18.8) | 0.0034 | |
RARB | 0 | 4 (12.5) | 0 | 0.144 | |
RASSF1A | 5 (22.7) | 10 (31.3) | 10 (62.5) | 0.72 | 0.09 |